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Abstract
Smart biomaterials play a key role when aiming at 
successful tissue repair by means of regenerative medicine 
approaches, and are expected to contain chemical as 
well as mechanical cues that will guide the regenerative 
process. Recent advances in the understanding of stem cell 
biology and mechanosensing have shed new light onto the 
importance of the local microenvironment in determining 
cell fate. Herein we report the biological properties of a 
bioactive, biodegradable calcium phosphate glass/polylactic 
acid composite biomaterial that promotes bone marrow-
derived endothelial progenitor cell (EPC) mobilisation, 
differentiation and angiogenesis through the creation of 
a controlled bone healing-like microenvironment. The 
angiogenic response is triggered by biochemical and 
mechanical cues provided by the composite, which activate 
two synergistic cell signalling pathways: a biochemical 
one mediated by the calcium-sensing receptor and a 
mechanosensitive one regulated by non-muscle myosin II 
contraction. Together, these signals promote a synergistic 
response by activating EPCs-mediated VEGF and 
VEGFR-2 synthesis, which in turn promote progenitor cell 
homing, differentiation and tubulogenesis. These findings 
highlight the importance of controlling microenvironmental 
cues for stem/progenitor cell tissue engineering and offer 
exciting new therapeutical opportunities for biomaterial-
based vascularisation approaches and clinical applications.
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Introduction
Regenerative medicine and tissue engineering implantation 
approaches rely strongly on two strategies to promote 
repair of the target tissue: a) the implantation of devices 
or constructs containing relevant in vitro cultured cells 
(classical tissue engineering), or b) biomaterials containing 
chemical or physical cues inducing the mobilisation of 
host cells capable of exerting the desired effects (in situ 
tissue engineering) (Hench and Polak, 2002; Lutolf et al., 
2009; Mooney and Vandenburgh, 2008; Rehfeldt et al., 
2007). From a practical point of view, the second approach 
is easier to implement in the clinic. Between 2002 and 
2004, the concept of smart biomaterials was introduced 
(also known as intelligent biomaterials or 3rd generation) 
(Hench and Polak, 2002; Anderson et al., 2004). In brief, 
these biomaterials possess two essential properties: 
biodegradability (they are resorbed into the host’s body 
without secondary effects) and bioactivity (they elicit a 
specific cell response) that make them suitable candidates 
for the application of in situ tissue engineering strategies 
(Hench and Polak, 2002).
 The lack of proper vascularisation in implanted 
biomaterials has largely hindered the efforts made to 
provide successful tissue substitutes. Most biomaterials 
fail from the start because improper blood supply leads 
to cell death at the implant site prompted by scarceness 
of nutrients (including O2), accumulation of waste 
products, impaired biochemical signalling and abnormal 
cell recruitment, resulting in an overall poor host 
integration (Santos and Reis, 2010). These problems can 
be circumvented by improving vascularisation in the local 
environment of the implant, and many efforts have been 
directed to clarify or solve the problem, mostly employing 
prevascularised or endothelialised constructs (Forster et 
al., 2011; Kneser et al., 2006). An alternative possibility 
implies the use of proangiogenic smart biomaterials able 
to recruit cells that actively participate in angiogenesis in 
vivo, such as endothelial progenitor cells (EPCs) (Larrivée 
and Karsan, 2007; Nomi et al., 2002). This would greatly 
simplify the preparation of the biomaterial previous to 
implantation, but more importantly, would facilitate 
vascularisation to proceed as in vivo, that is, coordinated 
with the host’s healing response (Nomi et al., 2002).
 EPCs are a heterogeneous subpopulation of bone 
marrow mononuclear progenitor cells with potential for 
differentiation to the endothelial lineage and demonstrated 
vasculogenic capacity (Asahara et al., 1997). In 
physiological conditions, EPCs are mobilised by growth 
factors and cytokines to the peripheral circulation, where 
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they home to sites of new vessel growth during injury or 
trauma (Takahashi et al., 1999). Since EPCs are a natural 
source of angiogenic cells and can be mobilised by 
biochemical stimuli, they are an attractive target of interest 
for vascularisation-oriented tissue engineering approaches 
and as such have received considerable attention in the last 
decade (Fuchs et al., 2006).
 In the context of bone tissue engineering, angiogenesis 
and osteogenesis are intimately linked, and it has been 
long suspected that both processes need to be correctly 
regulated for bone regeneration to occur (Aguirre et 
al., 2010b; Kanczler and Oreffo, 2008; Kirkpatrick et 
al., 2011; Li et al., 2011). This observation is true for 
muscular tissue too, given that it relies heavily on blood 
supply for its function (Koffler et al., 2011). In the case 
of bone, matrix formation starts with osteoblast-mediated 
collagen I deposition to form osteoid with angiogenesis 
occurring almost simultaneously. The matrix is gradually 
mineralised acquiring properties of mature bone (Kanczler 
and Oreffo, 2008). These bone healing sites consist of a 
complex mixture of mechanical signals determined by the 
matrix stiffness, and biochemical cues (growth factors, 
cytokines and ions). Together, these components establish 
a highly specific microenvironment that directs cell fate 
and tissue maturation. Initially, matrix elasticity properties 
of the bone healing microenvironment are mainly dictated 
by collagen I. Osteoid has an initial stiffness in the 30-
40 kPa range and increases as mineral deposition takes 
place (Engler et al., 2006). Mechanical forces exerted 
by the cells alter their shape and function through focal 
adhesions and actomyosin contraction, which lead to 
activation of intracellular signalling pathways (Ingber, 
2006; Ingber, 2008; Mammoto and Ingber, 2009, Engler 
et al., 2006). The process has been shown to be dependent 
on a non-muscle myosin II-dependent pathway that can 
be decoupled with the use of blebbistatin (a specific 
myosin inhibitor). A role for mechanosensing has been 
observed in endothelial cells, in which matrix elasticity 
dictates VEGFR-2 expression changes (Mammoto et al., 
2009; Mammoto et al., 2008). This mechanism enhances 
angiogenesis in matrices with elastic properties similar to 
those of blood vessel extracellular matrix (ECM).
 From a biochemical perspective, recent evidence 
suggests that the calcium-sensing receptor (CaSR), a 
membrane-bound G protein-coupled receptor, is involved 
in a biochemical pathway resulting in EPC recruitment and 
modulation of EPC-mediated angiogenesis (Aguirre et al., 
2010a). It is well-established that calcium acting through 
the CaSR promotes proliferation and differentiation in 
several cell types, including effects on endothelial cells, 
but also promotes important changes in bone cells such 
as osteoblasts and osteoclasts (Brown and MacLeod, 
2001; Mentaverri et al., 2006). Tissue-specific CaSR 
deficient mice exhibit grave defects in bone and cartilage, 
highlighting the importance of this poorly studied receptor 
in many physiological processes (Chang et al., 2008). In 
vivo experiments indicate that bone marrow progenitor 
cells are mobilised to sites of high calcium concentration 
– such as calcium releasing biomaterials – possibly by 
CaSR-mediated chemotaxis, suggesting a role of these cells 
in high extracellular calcium environments like resorbing 
bone (Adams et al., 2006; Tommila et al., 2009).
 The aim of this work was to explore the potential 
biological properties of a smart polylactic acid (PLA)/
calcium phosphate glass composite biomaterial over 
endothelial progenitor cells. The material, which was 
designed for in situ bone regeneration and vascularisation, 
has been described in detail before (Navarro et al., 2004). 
It mimics two of the bone healing microenvironment 
properties previously described: high extracellular calcium 
concentration and matrix stiffness analogous to osteoid. 
For these reasons, we hypothesised that our glass-based 
composite could induce a controlled angiogenic response 
when in contact with relevant stem cells involved in 
vascularisation, and thus we designed an in vitro assay 
model aimed at evaluating its proangiogenic performance. 
This system was also suitable for the study of biochemical 
(extracellular calcium) and mechanical cues (matrix 
stiffness) involved in the process.
Materials and Methods
Bioactive glass fabrication
Bioactive soluble glass (G5 glass) was produced in the 
system 44.5 P2O5 – 44.5 CaO – 6 Na2O – 5 TiO2 (molar %). 
For its fabrication, a homogeneous mixture of NH4H2PO4, 
Na2CO3, CaCO3 and TiO2 was melted in a platinum crucible 
at 1,350 ºC for 3 h, rapidly quenched and annealed at 
its transition temperature (533 ºC). Glass particles were 
obtained after milling in an agate planetary mill.
Fabrication of the composites
The biodegradable composites were elaborated by the 
solvent-casting method using NaCl as a porogen agent. 
PLA was dissolved in chloroform (5 % solution w/v) on 
an orbital shaker at 200 rpm. NaCl particles in the range 
of 80-210 µm and glass particles of <40 µm size were then 
added and mixed to create an homogeneous paste that was 
cast in Teflon moulds (6 mm diameter, 12 mm length). 
Once the chloroform had evaporated at room temperature 
the scaffolds were removed from the moulds, immersed 
in distilled water for two days (3 water changes per day) 
to eliminate the NaCl and left to dry in air. The resulting 
structures presented a highly interconnected porosity 
(~95 %), with a pore size diameter in the 80-210 µm 
range. Calcium phosphate glass films were generated by 
the sol-gel method using titanium, calcium, sodium and 
phosphorus alkoxides as precursors mixed in a proper ratio. 
The gels obtained were spin-coated for film production on 
flat Pyrex substrates. Films were then treated at 530 ºC to 
eliminate organics and reach the final glass structure and 
composition.
Cell seeding on the biomaterials
The scaffolds were cut into 3 mm thick slices, sterilised 
by immersion in 70 % ethanol for 1 min, rinsed in PBS 
and pre-incubated for 24 h in complete medium at 37 °C. 
Cells were seeded at a density of 40,000 cells/disc in 96-
well plates. In the case of G5 glass films, sterilisation was 
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carried out by brief immersion in 70 % ethanol followed 
by rinsing in phosphate-buffered saline (PBS) and pre-
incubation in complete medium. 80,000 cells/film were 
seeded on the film in 6-well plates at 37 ºC.
Isolation of rat bone marrow-derived endothelial 
progenitors
The protocol and the cell characterisation have been 
published elsewhere (Aguirre et al., 2010a; Liu et al., 
2007). In brief, bone-marrow was obtained from the 
long bones of young Lewis rats (2-4 weeks old) and the 
whole cellular fraction was resuspended in M199 (Sigma, 
St. Louis, MO, USA) supplemented with 20 % foetal 
bovine serum (FBS), 1 % pyruvate (Pyr), 1 % penicillin/
streptomycin (Pen/strep), 1 % L-glutamine (L-glu, 
Invitrogen, New York, NY, USA) and 22 µg/mL heparin 
(Sigma) and was plated in 1 µg/mL fibronectin-coated 
6-well plates (Nunc, Roskilde, Denmark) and incubated for 
24 h. Most adherent cells attached to the dish in this period, 
including mesenchymal stem cells, immature leukocytes, 
mature endothelial cells from vessels and others. The 
cells in suspension were then recovered and plated in new 
dishes for another 24 h. On the third day the suspension 
fraction, at this point highly enriched in haematopoietic 
cells, was again replated, this time with medium favouring 
EPC growth consisting of M199, 20 % FBS, 1 % Pyr, 
1 % Pen/Strep, 1 % L-glu, 22 µg/mL heparin, 20 ng/mL 
VEGF, 5 ng/mL bFGF, 20 ng/mL IGF1, 5 ng/mL EGF 
(Peprotech, Rocky Hill, NJ, USA) and 1 µg/mL ascorbate. 
Cells reached confluence after 8-9 d and were characterised 
as EPCs by both phenotypical and functional assays. Over 
time in culture, cells would lose progenitor-like properties 
and start to differentiate towards a more mature endothelial 
phenotype. To prevent this, only early passage cells were 
used in the experiments.
WST-1 cell viability and proliferation assay
Cells seeded at a density of 10,000 cells/well in 96-well 
plates and cultured in complete medium were incubated 
for 1 h with 1:10 WST-1 reagent (Roche Applied Science, 
Indianapolis, IN, USA) to determine mitochondrial 
dehydrogenase activity. The supernatant was taken to an 
ELISA plate reader to measure formazan dye formation by 
absorption at 450 nm.
Fluorescent determination of free calcium
A low-affinity fluorescent calcium indicator suitable for 
measurements of free calcium in cell culture medium 
was employed to determine calcium release from the 
material in cell-free conditions (Rhod-5N, Invitrogen). 
Rhod-5N binds strongly to calcium, being excited at 
552 nm and emitting at 581 nm. Medium samples were 
collected from control or biomaterial-incubated samples. 
A final concentration of 1 µM Rhod-5N was applied. A 
spectrofluorimeter (Shimadzu, Columbia, MD, USA) was 
then used to determine fluorescence emission. Fluorescence 
intensity values were extrapolated to the data obtained from 
a standard curve of known free calcium concentrations 
(ranging from 0 to 100 mM calcium).
Blebbistatin and CaSR antibody treatments
Blebbistatin (Sigma) was dissolved in DMSO and used at 
a final concentration of 20 µM. It was applied 4 h after cell 
seeding for 24 hour-long experiments or 24 h after seeding 
for 3 day-long experiments (it has been demonstrated 
that it is stable for up to 3 d in culture). It was verified 
that blebbistatin did not have negative effects on cell 
survival or chemotaxis (data not shown). CaSR antibodies 
(Affinity Bioreagents, Rockford, IL, USA) were used to 
block biochemical signalling through the calcium-sensing 
receptor (dilution 1:100). They were applied in the same 
pattern used for blebbistatin.
Immunofluorescence and microscopic imaging
Acridine orange (AO, Sigma) was used to visually 
determine cell morphology, distribution and number. 
Cells were incubated for 10 min with 10 µg/mL AO and 
washed twice with PBS. Imaging was performed with a 
stereomicroscope (Leica, Wetzlar, Germany) coupled to a 
CCD camera. For immunofluorescence, cells were cultured 
on glass coverslips or material for 24 h and fixed in 3 % 
paraformaldehyde for 10 min, blocked with 6 % bovine 
serum albumin (BSA) in PBS and permeabilised with 
0.1 % TX-100 solution for 10 min. Afterwards, they were 
incubated overnight at 4 °C with the following primary 
anti-rat antibodies: CaSR (Affinity Bioreagents), GATA2 
(Santa Cruz, Santa Cruz, CA, USA), TFII-I (Beckton-
Dickinson, Franklin Lakes, NJ, USA), NF-κB (Millipore, 
Billerica, MA, USA) and vinculin (Sigma), followed 
by incubation with secondary Alexa-488 fluorescent 
antibodies (Invitrogen) for 1 h at 37 ºC. Counterstaining 
was performed with phalloidin-rhodamine and DAPI 
(Invitrogen). Cells incubated with secondary antibody 
alone were used as negative controls. Images were obtained 
with a Leica SPE confocal microscope.
Chemotaxis assays
Transwell chambers with 8 µm pore diameter polycarbonate 
membranes (Corning, New York, NY, USA) were used 
to measure cell chemotaxis. Sub-confluent cells were 
trypsinised and 10,000 cells/well were seeded in the upper 
compartment of the chambers (previously pre-coated with 
a 10 µg/mL fibronectin solution). The medium used was 
M199, 1 % FBS, 1 % L-glu, 1 % Pen/Strep, 1 % Pyr, 
22.5 µg/mL heparin. The lower compartment of the wells 
was occupied by a scaffold disc (PLA, PLA/G5 or PLA/
G5 with CaSR antibodies or EGTA). Cells were allowed to 
migrate for 48 h (to allow for the degradation of the glass) 
and then were fixed in 10 % formalin (Sigma) and stained 
with DAPI. Nuclei from migrated cells were counted in 
4 different random fields of each sample and averaged. 
Controls denote chambers with no gradient (cell culture 
medium in upper and lower compartments), while positive 
control was a 40 ng/mL VEGF gradient.
Scanning electron microscopy (SEM)
Cells were fixed after 7 d growth in the different conditions 
in 2.5 % glutaraldehyde for 2 h, followed by a post-fixation 
step with 1 % osmium tetroxide, dehydrated in increasing 
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concentrations of ethanol (50 %, 70 %, 90 %, 96 % and 
100 %), critically point-dried and gold-sputtered.
Collagen I tube formation assay
Cells were harvested by trypsinisation and seeded at 
20,000 cells/well in growth factor free M199 with 1 % 
FBS, 1 % L-glu, 1 % Pen/Strep, 1 % Pyr and 22.5 µg/
mL heparin. After 4 d, phase contrast micrographs were 
taken. Branching was quantified by counting sprouting 
tube-like structures longer than 100 µm in 4 separate 
fields in duplicate samples. Cells stimulated with 40 ng/
mL VEGF were used as a positive control. For collagen I 
tube formation, a collagen I solution was diluted in culture 
media to a final concentration of 1.5 mg/mL collagen I (BD 
Bioscience, Franklin Lakes, NJ, USA) with addition of 1 N 
NaOH and 20 mM HEPES. The solution was carefully 
layered over the cells.
Angiogenesis qRT-PCR array
RNA was extracted from cells growing for 3 d in 
the different conditions (tissue culture polystyrene 
(TCPS), glass, PLA, PLA/G5) using a RNeasy Minikit 
(Qiagen, Venlo, Netherlands) following the manufacturer 
instructions. Reverse transcription of the samples was 
performed with a RT2 First Strand Kit (SABiosciences, 
Venlo, Netherlands). 0.5 µg cDNA and RT2 qPCR SYBR 
Green Master Mix (SABiosciences) were used in array 
plates containing a panel of 86 angiogenesis-related genes, 
5 housekeeping control genes, a rat genomic contamination 
control and RT-controls (Angiogenesis PCR array, PARN-
024Z, SABiosciences). Amplification was performed with 
a 10 min 95 ºC activation step followed by 40 cycles at 
95 ºC for 15 s (denaturation) and 1 min at 60 ºC (extension). 
Results were log converted, analysed using Euclidean 
distance and hierarchical clustering and represented as 
a heat map (Cluster and Java TreeView software). Gene 
ontology was performed using QuickGO. Only statistically 
significant results are shown.
VEGF protein quantification
Endothelial progenitors were seeded either in TCPS, 
glass or biomaterial at a density of 40,000 cells/well in 
growth factor and serum-reduced medium (1 % FBS). For 
PLA/G5, treatment with blebbistatin or CaSR antibodies 
was performed as described in “Blebbistatin and CaSR 
antibody treatments”. For 3 d, every 24 h, medium was 
recovered for VEGF protein quantification (Quantikine 
Rat VEGF Detection, R&D Systems, Minneapolis, MN, 
USA). A standard curve of known VEGF concentrations 
(0, 31.2, 62.5, 125, 250, 500, 1,000 and 2,000 pg/mL) was 
prepared. Samples were diluted 10 times in assay diluent 
and incubated for 2 h on an orbital shaker. Afterwards they 
were washed and incubated for 1 h with VEGF conjugate. 
Following extensive washing, substrate solution was added 
and incubated for 30 min. Optical density was determined 
at 450 nm for each well, including a blank and a negative 
control. Optical density values were transformed to pg/
mL using the standard curve values adjusted to a linear 
regression as recommended by the manufacturer. Results 
are normalised to cell number (as determined by counting 
in a haemocytometer after trypsinisation).
VEGFR-2 protein semi-quantification
Cells seeded at a density of 40,000 cells/wells either in 
glass, PLA or PLA/G5 scaffolds (untreated or treated 
with either blebbistatin or CaSR antibodies) for 24 h 
were washed with PBS, fixed in 3 % paraformaldehyde, 
permeabilised with TX-100 and blocked with 6 % BSA for 
1 h at 37 ºC. Afterwards, they were incubated overnight 
at 4 ºC with VEGFR-2 antibodies (Santa Cruz), followed 
by Alexa 488 secondary antibodies for 1 h at 37 ºC, 
counterstained with DAPI and mounted in microscope 
slides for confocal observation (Leica). The microscope 
laser settings were adjusted for optimal visualisation of 
the samples. All samples were imaged under the same 
conditions (laser intensity, objectives, zoom, pinhole size, 
etc). Pictures were taken in 4 different random fields in 
each sample. A section of 20 x 20 µm was selected and 
positioned over a cell. The image pixel intensity was then 
measured with ImageJ software (http://rsbweb.nih.gov/ij). 
The process was repeated 4 times per field, over a different 
cell each time. Afterwards the values were averaged and 
expressed relative to control substrate (glass).
Statistical analysis
Data are representative of at least 3 independent 
experiments, except where otherwise noted. Results are 
expressed as mean ± S.E.M. Statistical significance was 
determined by Student’s t-test (p < 0.05, two-tails).
Results
Material characterisation and calcium releasing properties
The composite biomaterial (PLA/G5) consists of a highly 
porous PLA matrix containing calcium phosphate bioactive 
glass particles (termed G5 glass, Fig. 1a, b). G5 glass has 
high controllable biodegradability which results in the 
liberation of biologically relevant ions to the medium, 
such as calcium (Navarro et al., 2004). In bulk solution, 
PLA/G5, but not PLA, releases an amount close to 0.5 mM 
calcium over a period of 8 d. G5 films also release calcium, 
although the kinetics are different and depletion of the 
film can be detected at 4 d (Fig. 1d). The total porosity 
of the composite scaffolds is ~95 %, with controlled pore 
size within the 80-210 µm range (Table 1). Considering 
previous work with glass-based materials, we speculated 
that PLA/G5 could possess proangiogenic potential (Day, 
2005; Xynos et al., 2000).
PLA/G5 promotes endothelial progenitor cell 
microcapillary-like tube formation
In order to test our hypothesis in a relevant setting for future 
applications, we established an in vitro EPC-biomaterial 
Table 1. PLA and PLA/G5 scaffold material properties 
relevant to cell behaviour.
PLA PLA/G5
Porosity (%) 92 ± 2.25 95.1 ± 1.51
Pore size (µm) 200-500 200-500
E (KPa) 74.5 ± 0.15 120 ± 0.03
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culture system. Bone marrow EPCs were seeded on 
different substrates: TCPS (negative control), PLA and 
PLA/G5 scaffolds (glass coverslip controls were also used 
but no difference was observed in comparison to TCPS, 
data not shown). TCPS was used as a negative control since 
EPCs do not form tube-like structures in this material and 
there are no biochemical signals aside from those in the 
cell culture medium. An additional experimental condition 
was created by adding a collagen I matrix to all materials 
(thus providing a positive proangiogenic environment) to 
have positive tube-forming conditions. Proliferation was 
similar in all materials and no cytotoxicity was detected 
up to 14 d (Fig. 1c). Collagen I somewhat delayed cell 
proliferation (Fig. 1c), but this was probably caused by 
the method of application (it has to be overlaid at 4 °C).
 Cell adhesion and morphology were followed for 
3 d (Fig. 2a) by fluorescent microscopy. EPCs grew to a 
monolayer on TCPS, with normal spread-out morphology. 
Fig. 1. Structural properties, cytotoxicity 
assay and calcium release of PLA/G5 
scaffolds. a) PLA/G5 scaffold side and up 
views. Scaffolds were 12 mm in length and 
6 mm in diameter. b) SEM micrographs 
show microstructure and the position of the 
glass microparticles in the PLA matrix. c) 
Cell viability measured by mitochondrial 
dehydrogenase activity at 3, 7 and 14 d 
(n = 4). d) Calcium release dynamics of 
control (medium alone), G5 glass films, 
PLA and PLA/G5 scaffolds to the medium.
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Fig. 2. PLA/G5 promoted in vitro EPC self-organisation into microcapillary-like 
structures. a) Microcapillary-like tube formation by EPCs seeded in TCPS, PLA 
or PLA/G5 scaffolds for 3 d in presence or absence of proangiogenic collagen 
I gel. Cells were stained with acridine orange (n = 3). Scale bar: 200 μm. b) 
Quantification of tubule formation. c) SEM micrographs of EPCs in PLA and 
PLA/G5 scaffolds after 7 d culture. Scale bar: 50 μm. Asterisk: G5 glass. Arrows: 
endothelial progenitor cells.
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PLA induced the aggregation into small round clusters, 
with occasional sprouting. PLA/G5 presented significantly 
higher numbers of tube-like structures when compared 
to TCPS (4.66 ± 0.63-fold versus 1 ± 0.04-fold) or 
PLA scaffolds (2.03 ± 0.22-fold) even in the absence of 
proangiogenic collagen I gel (Fig. 2a, b, n = 4, p < 0.05). 
These structures were not limited to pore-lining cells, but 
would also develop across pores or penetrate further into 
the material. As expected, the collagen matrix induced 
tubulogenesis on TCPS and PLA, and although it also 
increased EPC tube formation in PLA/G5, the difference 
was not significant when compared to naked PLA/G5, 
suggesting that cells already had an active proangiogenic 
program in motion (Fig. 2a, b). The same trend was 
observed in 7 and 14 d cultures (data not shown). SEM 
analysis provided information on cell interaction with the 
composite. EPCs seeded on PLA exhibited poor attachment 
and a tendency to self-contact, forming monolayer-like 
clusters (Fig. 2c). PLA/G5 induced cells to elongate and to 
contact each other. In many cases, cells used glass particles 
as anchorage points (Fig. 2c).
Endothelial differentiation and proangiogenic gene 
expression takes place when EPCs are cultured in 
PLA/G5 by activation of VEGF-VEGFR2 signalling
To confirm that angiogenesis was taking place, gene 
expression analyses for a panel of endothelial and 
angiogenic markers was carried out. PLA/G5 induced 
significant changes in EPC gene expression (43 % of 
the tested genes were up-regulated), which were further 
characterised by gene ontology. 44 % of the genes were 
involved in signalling and endothelial differentiation 
(such as EphA, IGF1, EDG1, ECGF1, PDGF-A, CD31 
and Itgα3), 12 % in general proliferation and 7 % in 
Fig. 3. PLA/G5-mediated EPC differentiation and proangiogenic cytokine production. a) Real-time RT-PCR 
changes in angiogenic gene expression profiles in the different conditions. Only significantly up-regulated genes 
are shown. Results were expressed relative to TCPS-seeded EPCs (n = 4, p < 0.05). b) Real time RT-PCR for VEGF 
and VEGFR-2 showed a significant up-regulation when cells were in contact with PLA/G5. Results were expressed 
relative to TCPS-seeded EPCs (n = 4, p < 0.05). c) Protein quantification was measured by ELISA (for VEGF) or 
by immunofluorescent intensity semiquantification after 3 d culture. VEGFR-2 results are expressed as fold increase 
over glass (n = 3, p < 0.05).
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Fig. 4. Biochemical signals carried by 
PLA/G5 induced chemotaxis in EPCs 
through activation of the CaSR. a) 
Immunofluorescent localisation of CaSR 
in PLA/G5-seeded EPCs. Scale bar: 50 μm. 
b) EPCs were chemotactically attracted 
towards PLA/G5 as shown by Boyden 
chamber assays. VEGF was used as positive 
control. Results expressed relative to control 
migration (n = 4, p < 0.05). c) PLA/G5-
mediated EPC chemotaxis and its calcium 
dependency. Results expressed relative 
to control migration (n = 3, p < 0.05). d) 
Bright field micrographs show that PLA/G5 
scaffolds were more attractive to EPCs than 
their PLA counterparts. Scale bar: 100 μm.
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extracellular matrix remodelling (Mmp3, Mmp9). This 
behaviour was not observed in glass or PLA (Fig. 3a), but 
it was possible to reproduce proangiogenic gene expression 
on G5 glass films manufactured by sol-gel fabrication. 
Cells on these films up-regulated CD31 and vWF factor 
expression significantly, although microscopical evaluation 
showed no tube formation or evident morphological 
changes (data not shown).
 Given the importance of the VEGF-VEGFR2 signalling 
axis in vascular development, EPC changes in these two 
factors were determined after 3 d in PLA/G5 (Fig. 3b). 
VEGF and VEGFR-2 mRNA were significantly up-
regulated when cells were in contact with PLA/G5 (1.3 
± 0.01-fold for VEGF and 1.4 ± 0.08-fold for VEGFR-2). 
Glass and PLA induced no significant differences either in 
VEGF (0.87 ± 0.32-fold and 0.75 ± 0.06-fold, respectively) 
or VEGFR-2 expression (1.02 ± 0.1-fold and 1.18 ± 0.05-
fold, respectively). Results were expressed relative to 
TCPS-seeded EPCs (n = 4, p < 0.05). At the protein level 
(Fig. 3c), after 3 d culture, EPCs had increased VEGF 
production in PLA/G5 (20.64 ± 1.48 ng/mL) compared 
to TCPS (14.73 ± 0.75 ng/mL), glass (13.61 ± 0.62 ng/
mL) or PLA (16.99 ± 0.12 ng/mL), and also higher levels 
of VEGFR-2 membrane expression (1.46 ± 0.09-fold for 
PLA/G5, 1 ± 0.08-fold for TCPS and 1.22 ± 0.02-fold for 
PLA). VEGFR-2 results were expressed as fold increase 
over glass (n = 3, p < 0.05).
Material-mediated calcium release and matrix 
stiffness properties are essential for EPC migration 
and tube formation
G5 glass releases significant amounts of free calcium 
upon degradation (Fig. 1d), regardless of the fabrication 
procedure (melting in solvent casting PLA/G5 scaffolds 
or sol-gel in the case of films). EPCs cultured on PLA/G5 
scaffolds expressed CaSR at the cell membrane (Fig. 4a). 
Previous data show that this receptor is functionally active 
in EPCs and exerts modulatory effects on differentiation 
and their angiogenic properties (Aguirre et al., 2010a). 
We hypothesised that PLA/G5 effects could be, at least in 
part, mediated by its calcium-releasing properties. CaSR-
mediated chemotaxis was determined in Boyden chamber 
assays to examine the EPC migratory response to PLA/
G5 (Fig. 4b). EPCs were chemotactically attracted towards 
PLA/G5 (1.98 ± 0.17), but not to PLA (1.06 ± 0.14). 
VEGF was used as positive control (2.19 ± 0.11). PLA/
G5-mediated chemotaxis was completely blocked by anti-
CaSR (1.03 ± 0.09) or by removal of extracellular calcium 
with the calcium chelator EGTA (0.97 ± 0.13, results 
expressed relative to control migration, n = 3, p < 0.05, Fig. 
4c). On a different experimental setting, EPCs seeded in 
PLA/G5 or PLA scaffolds were placed in plastic dishes and 
observed for 4 d. A significant amount of cells detached or 
were actively migrating out of the PLA material; however, 
they were attracted to PLA/G5 (very few cells were seen 
leaving the biomaterial, Fig. 4d).
Fig. 5. EPC cytoskeletal stress and focal adhesion formation were affected by PLA/G5. Cell morphology and 
cytoskeletal organisation were evaluated by confocal observation of the actin cytoskeleton and focal adhesions (red: 
actin, green: vinculin). Cells in glass exhibited high tension and spreading, with focal adhesion formation over the 
cell periphery. PLA and PLA/G5-seeded cells adopted an elongated morphology with lower tension (actin stress 
fibres were still visible but less frequent, and vinculin appeared diffuse in the cytosol). Blebbistatin-treated cells lost 
most of their cytoskeletal organisation. Scale bar: 50 μm.
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Fig. 6. PLA/G5-mediated EPC proangiogenic behaviour can be eliminated by inhibition of either calcium-sensing 
or matrix stiffness-mediated mechanotransduction. a) Fluorescent micrographs showing EPC tube formation in 
PLA/G5, PLA/G5 treated with CaSR blocking antibodies, or inhibition of NMII contraction with blebbistatin. Scale 
bar: 200 μm. b) Quantification of tube formation in PLA/G5-seeded cells before treatment and after antibody or 
blebbistatin treatment. Results expressed as fold increase over cells in TCPS (n = 3, p < 0.05). c) Real time RT-PCR 
array experiments indicated a strong impairing of the differentiation process when CaSR antibodies or blebbistatin 
were applied. Results expressed relative to TCPS-seeded EPCs (n = 4, p < 0.05). d) Quantification of VEGF and 
VEGFR-2 expression before and after treatment with CaSR blocking antibodies or blebbistatin. Results expressed 
relative to cells growing on TCPS (n = 3, p < 0.05). e) Protein synthesis of VEGF or VEGFR-2 measured by ELISA 
(for VEGF) or intensity semi-quantification (VEGFR-2). Protein results expressed relative to cells growing on glass 
(n = 3, p < 0.05).
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Fig. 7. Biomaterial effects are mediated by nuclear translocation of transcription factors associated to the CaSR and 
mechanosensing. a) Nuclear presence of GATA2, TFII-I and NF-kB transcription factors was determined by confocal 
microscopy on EPCs growing on glass, PLA/G5 or PLA/G5 with one of the inhibitors (αCaSR, blebbistatin) after 
24 h incubation. b) Quantification of activated cells for each transcription factor. Results expressed as percentage of 
cells showing activated nuclei (n = 4, p < 0.05).
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 We studied cell morphology and focal adhesion 
formation at 24 h by confocal microscopy. It revealed 
that both PLA/G5 and PLA induced lower levels of actin 
organisation and diffuse vinculin staining in focal adhesion 
formation when compared to glass, indicating a different 
mechanical state. Only EPCs seeded on PLA/G5 exhibited 
the elongated morphology that precedes tube formation, 
suggesting the involvement of another factor which was 
not present in PLA scaffolds (Fig. 5). Treatment with anti-
CaSR of cells seeded on PLA/G5 had no immediate effect 
on cytoskeletal organisation or elongated morphology, 
but inhibition of actomyosin contraction with blebbistatin 
strongly disrupted the development of elongated cells, 
again indicating a contribution of mechanosensing to the 
process of EPC tube formation (Fig. 5). Blebbistatin, at the 
concentration employed (20 µM), did not exert negative 
effects on cell proliferation or chemotaxis under any of the 
conditions (data not shown).
PLA/G5-mediated gene expression changes are 
strongly dependent on extracellular calcium and 
matrix stiffness
We tested if addition of either anti-CaSR or blebbistatin 
could abolish PLA/G5-mediated tube formation after 3 d 
(Fig. 6a, b). Quantification of tube formation in PLA/G5-
seeded cells before treatment (7.25 ± 0.53-fold) and after 
antibody (2.44 ± 0.20-fold) or blebbistatin treatment (0.85 
± 0.19-fold) showed significant differences when any of 
these signal transduction pathways were blocked (n = 3, 
p < 0.05). Blockade of the CaSR resulted in a significant 
disorganisation characterised by a more random cell 
distribution throughout the material, but morphologically 
normal cells. Blebbistatin produced cell rounding, but 
did not affect attachment or proliferation. Any of the two 
treatments resulted in marked decrease in tube formation 
(Fig. 6a, b). When both treatments were applied together 
cell death increased and adhesion to the biomaterial 
dramatically decreased, so no further tests were carried 
out for that condition (data not shown).
 It was expected that proangiogenic gene expression 
changes induced by PLA/G5 would be reverted by 
treatment with anti-CaSR or blebbistatin (Fig. 6c). 
Application of CaSR blocking antibodies or blebbistatin 
led to important down-regulation of the pathways activated 
by PLA/G5 (54 % genes inhibited by anti-CaSR and 
64 % by blebbistatin), confirming that CaSR-mediated 
signalling and mechanosensing played major roles in 
PLA/G5-mediated EPC proangiogenic differentiation. 
We determined before that VEGF and VEGFR-2 were 
important actors in the PLA/G5-mediated cell response. 
To clarify if VEGF and VEGFR2 up-regulation were 
CaSR and/or blebbistatin-sensitive, we treated PLA/G5-
seeded cells with them and measured VEGF and VEFGR2 
expression and synthesis (Fig. 6d, e). PLA/G5-induced 
VEGF up-regulation (1.3 ± 0.01-fold) was significantly 
reduced by treatment with anti-CaSR (1.10 ± 0.05-fold) 
or blebbistatin (1.05 ± 0.06-fold). VEGFR-2 transcription 
(1.40 ± 0.08-fold) was affected by blebbistatin (0.98 
± 0.03-fold), but not by anti-CaSR (1.35 ± 0.06-fold, n = 3, 
p < 0.05). Protein amount confirmed mRNA results. PLA/
G5-induced VEGF protein production (20.64 ± 1.48 ng/mL 
versus 14.73 ± 0.75 ng/mL for TCPS) was abolished by 
anti-CaSR (12.73 ± 0.91 ng/mL), EGTA (8.89 ± 0.19 ng/
mL) and blebbistatin (12.93 ± 0.72 ng/mL). In the case of 
PLA/G5-induced VEGFR-2 synthesis (1.46 ± 0.08-fold), 
the process was inhibited by blebbistatin (0.93 ± 0.24-fold) 
but largely unaffected by anti-CaSR (1.38 ± 0.06-fold, 
n = 3, p < 0.05).
EPC differentiation is promoted by NF-κB and 
GATA2 transcription factor activation through the 
calcium-sensing receptor and non-muscle myosin II
Transcription factors regulate gene expression changes. 
NF-kB, GATA2 and TFII-I have been involved in 
endothelial differentiation and mechanosensing. Nuclear 
translocation of these factors was observed in EPCs that 
had been in contact with PLA/G5 for 24 h (Fig. 7a, b). 
Levels of GATA2 in the nucleus were higher in PLA/G5-
seeded cells (65.5 ± 5 % activated cells) compared to glass 
(23 ± 13 %). This activation was significantly reduced when 
cells were treated with blebbistatin (29 ± 8 %), but it was 
left unaffected by anti-CaSR antibodies (57.5 ± 6.5 %). 
Although TFII-I levels in the nucleus of PLA/G5-treated 
cells were lower, no significant differences were detected 
in any condition (glass: 79 ± 8 %; PLA/G5: 61.5 ± 3.5 %; 
anti-CaSR: 59.5 ± 2.5 %; blebbistatin: 66 ± 7 %). NF-κB 
translocation was significantly increased in PLA/G5-
seeded cells (72 ± 3 %) compared to glass (42.5 ± 2.5 %). 
The process was suppressed by cell treatment with either 
anti-CaSR (21 ± 5 %) or blebbistatin (31.5 ± 8.5 %).
Discussion
The need for more sophisticated biomaterials which are 
able to induce specific tissue responses with minimal side 
effects has pushed the boundaries of materials science to 
new levels of sophistication (Mooney and Vandenburgh, 
2008). Despite on-going efforts, implants frequently 
fail to meet this goal. In many cases this is due to a lack 
of understanding of the biological processes involved, 
including the interactions at the cell-biomaterial interface. 
In this study we have employed a composite biomaterial 
for bone tissue engineering applications based on calcium 
phosphate glass and PLA (PLA/G5). Both PLA and 
calcium phosphate are approved for use in humans and 
present a good resorption rate. In previous studies, it has 
been determined that the material performs acceptably in 
vivo, suggesting glass bioactivity, but unexpectedly, it also 
induced significant osteon formation (Sanzana et al., 2008). 
The relationship between osteons and bone vascularisation 
is well-known, so we hypothesised that the material could 
have vascularising properties (Kanczler and Oreffo, 
2008). An in vitro progenitor cell model of angiogenesis 
was developed to this end, which could also be employed 
to clarify the on-going biological mechanisms, so that 
these data could be extrapolated for future biomaterials 
design. Endothelial progenitor cells (EPCs) were ideal for 
this purpose since their role in vascularisation has been 
extensively characterised (Asahara et al., 1997; Larrivée 
and Karsan, 2007; Takahashi et al., 1999).
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 EPCs obtained from bone marrow were seeded on 
PLA/G5 three-dimensional discs and the effects on cell 
morphology, proliferation and differentiation were studied. 
We found that PLA/G5 did not affect cell proliferation (Fig. 
1c), but could induce morphological changes leading to 
microcapillary-like tube formation as early as 3 d (Fig. 2a, 
b, c). This was followed by consistent broad up-regulation 
of proangiogenic genes and endothelial markers (Fig. 3a). 
When analysed by gene ontology, it could be established 
that the majority of these genes were either involved in 
proliferation, signalling or differentiation, with a smaller 
number committed to chemotaxis, matrix proteolysis and 
cell adhesion. These findings fitted well with the other 
previous observations. Of special importance, the potent 
proangiogenic mediator proteins VEGF and VEGFR-2 
(Fig. 3b, c) were also up-regulated, although increases 
at the mRNA level were modest; protein synthesis levels 
for VEGF and VEGFR-2 indicated a 40 % and 46 % 
induction, respectively. When these changes were taken 
into consideration combined with the other up-regulated 
proangiogenic markers and cytokines (Fig. 3a), they 
suggested a solid proangiogenic profile. A possible 
explanation for this system involves the development over 
time of a mixed cell population with different lineages 
(cells producing VEGF and cells expressing VEGFR2). 
This is in agreement with other authors’ findings, which 
indicate that EPCs are an heterogeneous population of 
cells related to the vascular lineage (Asahara et al., 1997). 
VEGF is a critical growth factor necessary for blood 
vessel formation, both in the adult and the developing 
embryo (Holmes et al., 2007; Nomi et al., 2002). It 
signals through its tyrosine kinase receptor, VEGFR-2, 
activating a wide array of responses (chemotaxis, survival 
and proliferation, cytoskeletal rearrangement) (Holmes et 
al., 2007). In our setting, the finding that both VEGF and 
VEGFR-2 experienced a significant increase offered a 
possible explanation for the PLA/G5 effects, since it would 
create a positive, proangiogenic signalling feedback loop. 
However, we cannot exclude that other proangiogenic 
pathways were involved (and as a matter of fact, several 
other angiocrines, such as angiopoietin-1 and 2 were also 
up-regulated), although our results suggested that VEGF 
signalling was one of the main driving forces behind PLA/
G5 effects.
 Previous studies have shown that glass-based materials 
such as Bioglass can induce proangiogenic cytokine 
production in fibroblasts and thus angiogenesis indirectly, 
but no data on endothelial progenitors was available (Day, 
2005). The mechanism of action for Bioglass remains 
largely unexplained, although it likely involves bioactive 
ion release (Xynos et al., 2000; Xynos et al., 2001). In our 
case, the setting was more complex since the biomaterial 
was a composite formed by an inert matrix (PLA) and 
the calcium phosphate bioactive glass. We determined 
that the glass dissolves releasing  biologically relevant 
amounts of calcium, up to 0.6 mM in bulk solution 
(Fig. 1), which was in agreement with previous results 
(Navarro et al., 2004). Biologically, extracellular calcium 
plays an important role in proliferation, chemotaxis and 
differentiation through a membrane-bound G protein-
coupled receptor named calcium-sensing receptor (CaSR) 
(Brown and MacLeod, 2001). Furthermore, calcium can 
be present at high concentrations in the extracellular 
fluids of tissues undergoing remodelling, such as healing 
bone (Silver et al., 1988). Recently, we described a role 
for this receptor in EPC maturation and chemotaxis, thus 
offering a partially satisfactory biochemical explanation 
for the results observed with PLA/G5 (Aguirre et al., 
2010a). However, and although PLA is chemically inert, 
it contributes to the cell microenvironment by providing a 
certain matrix stiffness which, joined to the high porosity 
and G5 glass, can be relevant for cell differentiation 
through mechanosensation.
 In recent years, there has been a growing interest 
in the mechanical properties of the extracellular matrix 
(Engler et al., 2006). In vivo, cells are embedded in a three-
dimensional, tissue-specific matrix with defined stiffness 
properties which presents information to the cells in the 
form of mechanical stress. Recent experiments have shown 
that 2D surfaces affect differentiation of stem cells (Engler 
et al., 2006; Mammoto et al., 2008). Other studies suggest 
that the effects are stronger and more efficiently transmitted 
in 3D gels (Byfield et al., 2009). In our biomaterial, cells are 
initially exposed to a 2D environment with topographical 
features which likely evolves into a 3D setting over time 
(as extracellular matrix deposition takes place). The role of 
matrix stiffness in PLA/G5 was foreseen when the contact 
with the biomaterial yielded significant morphological 
changes in EPCs which could not be related to topography, 
since it was roughly equivalent for PLA and PLA/G5 (Fig. 
5). PLA/G5 macroscopic stiffness had been determined to 
be approximately ~120 kPa (Table 1) (Navarro et al., 2004).
We speculated that the material structure allowed cells 
to sense a real stiffness closer to that of PLA (~70 kPa), 
since G5 glass particles are embedded and suspended in 
the PLA matrix, and thus forces exerted over G5 glass 
particles are transmitted through deformation. In this 
setting, the stiffness sensed by cells would be closer to 
that of osteoid (30-100 kPa, depending on the maturation 
stage) (Engler et al., 2006) and would thus support the 
hypothesis that PLA/G5 mimics osteoid to a certain extent. 
Furthermore, mathematical modelling and simulations 
showed that at the microscopic scale, PLA/G5 stiffness 
was closer to 25-40 kPa when microstructure and pore 
architecture was included in the calculations (unpublished 
observations by Prof. D. Lacroix), a number which is very 
close to the biological stiffness of osteoid. Osteoid is also 
a potent proangiogenic environment that collaborates in 
bone vascularisation (Kanczler and Oreffo, 2008). Also, 
mechanosensation plays a relevant role in endothelial 
cell tube formation. We observed that matrix stiffness 
was somehow affecting EPC differentiation because cell 
morphology and mechanical state (that is, the tension the 
cells feel and exert in relation to the extracellular matrix) 
were radically different between tissue culture glass and 
PLA/G5 culture conditions (Fig. 5).
 We hypothesised that if calcium and matrix 
stiffness were collaborating to create a proangiogenic 
microenvironment, blockade or inhibition of any, or both, 
should result in reduced EPC proangiogenic behaviour 
when in contact with PLA/G5. To test this hypothesis, 
two different treatments were used on PLA/G5 seeded 
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Fig. 8. Schematic model summarising the effects and underlying mechanisms of EPC activation by PLA/G5. 
Cells receive information from the material through calcium released by the bioactive G5 glass. This calcium 
activates the G protein-coupled receptor CaSR. At some point, signalling through the CaSR provokes nuclear 
translocation of NF-kB that results in increased VEGF-A transcription leading to angiogenesis (an unexplored 
pathway depending on mechanotransduction is also possible). On the other hand, mechanical signals pertaining 
to the material stiffness, which in biological terms is similar to that of osteoid, activate transcription factors 
affecting differentiation (GATA2, NF-kB). The result is the up-regulation of VEGFR-2 transcription and protein 
synthesis leading to angiogenesis. Thus, biochemical activation and mechanical signalling synergistically promote 
self-organisation, angiogenesis and differentiation in EPCs.
cells. On one hand, calcium signalling was abolished with 
anti-CaSR specific blocking antibodies. On the other hand, 
mechanosensing was inhibited by preventing actomyosin 
contraction. For this purpose blebbistatin, a specific non-
muscle myosin II inhibitor, was used (Engler et al., 2006). 
Blebbistatin can cause a number of secondary effects on 
cells, depending on dose and cell type (Goeckeler et al., 
2008; Liu et al., 2010; Wang et al., 2008). We characterised 
the EPC response to blebbistatin to make sure that the 
effects observed were not the consequence of toxicity 
(data not shown). Low blebbistatin concentrations (20 μM) 
with no side effects were employed in all subsequent 
experiments, reasoning that it was not necessary to 
completely shut down mechanosensation to observe the 
inhibitory effects over PLA/G5-mediated proangiogenic 
activation. Abolishing calcium signalling was sufficient 
to drastically reduce VEGF production, while blocking 
mechanosensation affected both VEGF and VEGFR-2 
production. Any of the two treatments would cause a 
dramatic reduction in tube formation and proangiogenic 
differentiation mediated by PLA/G5, supporting the notion 
observed before: that a VEGF/VEGFR-2 feedback loop 
was necessary for sustained PLA/G5 effects (Fig. 6).
 Global gene expression changes as those seen in the 
case of EPCs cultured on PLA/G5 are usually mediated 
by master regulators such as transcription factors. 
Experiments were performed to check the potential 
role of GATA2, TFII-I and NF-кB in PLA/G5-mediated 
effects, since they have been shown to be involved in 
angiogenesis through the CaSR (Hammond et al., 2007; 
Martin et al., 2009) and mechanosensing by regulating 
VEGF and VEGFR-2 expression (Mammoto et al., 2009). 
If active, both the CaSR and mechano-sensation can 
activate complex downstream signalling that results in 
transcription factor nuclear translocation (Fig. 6, Engler 
et al., 2006; Mammoto et al., 2008; Spencer et al., 2010). 
It has been shown that CaSR can affect NF-ҝB through a 
PLC (phospholipase C)-dependent pathway in osteoclasts, 
where local extracellular calcium regulates bone resorption 
(Mentaverri et al., 2006) and also in endothelial cells 
(Martin et al., 2009). Among other numerous effects, NF-
ҝB regulates VEGF transcription (Martin et al., 2009). 
We could establish that NF-ҝB translocation and VEGF 
production were calcium-sensitive (Fig. 5d, e and Fig. 
6). In other publications, authors linked matrix stiffness 
to nuclear translocation of GATA2 (a fundamental 
transcription factor in haemangioblastic development 
(Lugus et al., 2007)) and TFII-I through mechanosensing 
in endothelial cells (Mammoto et al., 2009). In our setting, 
GATA2, but not TFII-I, was blebbistatin-sensitive, as well 
as VEGF and VEGFR-2 synthesis, supporting previous 
data and offering new insights into the mechanism of action 
of mechanosensation in endothelial progenitors (Fig. 7).
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 Calcium is an important modulator of cell activities 
and can be considered a drug for biological purposes. 
The results presented herein suggest that the combination 
of a precise set of material properties can efficiently 
elicit controlled cellular responses of interest for tissue 
engineering and biomaterials science. It would be a 
mistake to think that calcium alone can induce specific 
responses (such as growth factors) in many different cell 
types. Its properties should be exploited in combination 
with the appropriate set of growth factors/morphogens. 
However, calcium can probably induce, at least partially, a 
specific response in cell types intimately linked to calcium 
homeostasis in calcium-rich tissues (e.g. bone or bone 
marrow).  In our particular case of interest (bone tissue 
engineering and musculoskeletal repair), it is exciting to 
think that the in vivo performance of certain biomaterials 
and their clinical relevance could be boosted by careful 
addition of calcium and tailored tissue-like mechanical 
properties, possibly combined with adequate growth 
factors.
 Summarising, PLA/G5 was able to promote EPC 
angiogenesis by partially mimicking properties of 
the physiological bone healing microenvironment. 
Activation of the angiogenic program was carried out by 
two independent, but related, signalling pathways, one 
depending on biomaterial-released extracellular calcium 
and another relying on mechanotransduction. This model 
is represented and explained in detail in Fig. 8. We did not 
rule out the involvement of other proangiogenic factors 
up-regulated in our experiments, but could determine that 
VEGF/VEGFR-2 is one of the main driving forces behind 
the effects of the biomaterial.
Conclusions
We have developed a smart composite biomaterial exerting 
proangiogenic and chemotactic properties on EPCs by 
mimicking some qualities of the healing bone matrix 
microenvironment. To the extent of our knowledge, 
this is the first time that a composite containing a 
bioactive, biodegradable glass has been proven to be 
directly involved in angiogenesis and differentiation 
of endothelial progenitors. The main advantages of 
this approach (when compared to others such as 
protein immobilisation or growth factor release) are the 
simplicity of material fabrication, low cost and off-the-
shelf availability, making it a very attractive strategy for 
clinical applications involving musculoskeletal repair. 
Future work will involve the development of new, more 
practical, fabrication techniques, as well as variations 
of the glass composition (to tune calcium release) that 
will have to be tested in vitro and in vivo. Moreover, 
our work integrated previous findings in the fields of 
mechanotransduction and biochemistry to build up a 
model of the underlying biological interactions on-going 
at the cell-material interface. The biological properties 
of the material were mainly attributed to two parameters 
affecting the cell local environment: extracellular calcium 
(acting through the CaSR) and material stiffness (through 
NMII cytoskeletal contraction and signalling). These two 
pathways contribute to cell differentiation and tube-like 
formation through activation of gene expression. This 
mechanistic insight could contribute to the rational design 
of future, proangiogenic smart biomaterials.
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Discussion with Reviewers
Reviewer I: The authors use blebbistatin, which is known 
to rapidly and locally decouple the cytoskeleton from the 
plasma membrane, thereby disrupting cell migration and 
cytokinesis but without affecting mitosis. Blebbistatin 
therefore is expected to disrupt cell elongation. The authors 
conclude that this is a proof that mechanosensation is 
involved in EPC tube formation, but this is a major over-
interpretation of such results. It is indeed very likely that 
blebbistatin would have similar effects on every material 
(e.g. TCPS or PLA). Surprisingly, the authors mention that 
blebbistatin at this dose did not affect chemotaxis. It is hard 
to believe that blebbistatin strongly affects the elongation 
of EPCs, but has no inhibitory effect on migration. Is 
blebbistatin therefore a good choice? Are there alternative 
approaches/drugs?
Authors: 1) In our experiments, blebbistatin was used at 
a low concentration (20 µM, less than half of that used by 
Engler et al. (2006) and other authors). At this concentration, 
we never observed disruption of cell motility, chemotaxis 
or cell death, even after 3 d of continuous administration. 
We wanted to exclude the possibility of our results being 
produced by a possible cytotoxicity. In that respect, we 
are well below the slightest sign of toxicity. 2) At the 
concentration used in the experiments, we did not observe 
a disruption of cell elongation caused by blebbistatin. The 
only visible change in cell morphology was a tendency of 
the cell to partially shrink around the edges. All other cells 
parameters tested (survival, etc.) were normal. However, 
the reviewer is right in noticing that blebbistatin could 
affect cell elongation, thus the effect would be the same 
in PLA, TCPS, etc. We took further precautions to prevent 
this problem by always applying blebbistatin 4 h or 24 h 
after cell seeding, thus allowing the cells to adhere and 
elongate under normal and equal starting conditions for 
all materials. 3) Reports on the effects of blebbistatin 
over cell chemotaxis are contradictory. Some authors 
find enhanced motility (Liu et al., 2010; Niggli et al., 
2006), while others inhibition (Wang et al., 2008). These 
discrepancies might arise from the different cell types 
and concentrations employed. For our experiment, we 
empirically determined the effects of blebbistatin over 
chemotaxis and cell survival. These data were not included 
in the original manuscript submission for lack of space and 
because they do not add any information to the findings 
of the manuscript itself. In those experiments, we find no 
effect of blebbistatin on EPC migration or survival at the 
concentrations used in our experiments (20 µM).
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